KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Other Operating Expenses (2016 - 2026)

Tenet Healthcare (THC) has disclosed Other Operating Expenses for 17 consecutive years, with $413.0 million as the latest value for Q1 2026.

  • For Q1 2026, Other Operating Expenses changed N/A year-over-year to $413.0 million; the TTM value through Mar 2026 reached $413.0 million, up 1432.26%, while the annual FY2024 figure was -$35.0 million, 25.53% up from the prior year.
  • Other Operating Expenses hit $413.0 million in Q1 2026 for Tenet Healthcare, up from -$17.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $413.0 million in Q1 2026 and bottomed at -$20.0 million in Q1 2022.
  • Average Other Operating Expenses over 4 years is $20.1 million, with a median of -$12.0 million recorded in 2022.
  • Year-over-year, Other Operating Expenses crashed 53.85% in 2022 and then skyrocketed 80.0% in 2023.
  • Tenet Healthcare's Other Operating Expenses stood at -$20.0 million in 2022, then rose by 5.0% to -$19.0 million in 2023, then grew by 10.53% to -$17.0 million in 2024, then soared by 2529.41% to $413.0 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $413.0 million, -$17.0 million, and -$9.0 million for Q1 2026, Q4 2024, and Q3 2024 respectively.